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Abstract
 
Macrophage clearance is essential for the resolution of inflammation. Much is known about
how monocytes enter the inflammatory site but little is known about how resultant macro-
phages are cleared. We have previously demonstrated that macrophage clearance from resolving
peritonitis occurs by emigration into draining lymphatics rather than local apoptosis. We now
examine mechanisms for this process, in particular by evaluating the hypothesis that modulation
of adhesion interactions between macrophages and cells lining the lymphatics regulates the rate
of macrophage clearance. We demonstrate in vivo that macrophages adhere specifically to me-
sothelium overlying draining lymphatics and that their emigration rate is regulated by the state
of macrophage activation. We observed that macrophage–mesothelial adhesion is Arg-Gly-Asp
(RGD) sensitive and partially mediated by very late antigen (VLA)-4 and VLA-5 but not 
 
 
 
v 
 
or
 
 
 
2 
 
integrins. Moreover, macrophage clearance into lymphatics can be blocked in vivo by RGD
peptides and VLA-4 and VLA-5 but not 
 
 
 
2 
 
blocking antibodies. This is the first evidence that
macrophage emigration from the inflamed site is controlled and demonstrates that this is exerted
through specific adhesion molecule regulation of macrophage–mesothelial interactions. It high-
lights the importance of adhesion molecules governing entry of cells into the lymphatic circula-
tion, thus opening a new avenue for manipulating the resolution of inflammation.
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Introduction
 
The mechanisms regulating the resolution of inflammation
have been studied in detail for the neutrophil (1). How-
ever, the role of the macrophage in this process has re-
ceived little attention. Macrophage clearance in acute re-
solving peritonitis is known to occur by emigration to the
draining lymphatics rather than by local apoptosis, but the
mechanisms regulating this are unknown (2). Kinetic stud-
ies on macrophages within the peritoneum imply that resi-
dent and inflammatory macrophages have dramatically
different half-lives, which suggests that macrophage clear-
ance might be regulated, a concept that has not been previ-
ously investigated (2, 3). Macrophages are central to effec-
tive wound healing (4). However, their accumulation is
also a hallmark of chronic inflammation where they can
potentiate tissue damage (5). Moreover, the elimination of
macrophages from sites of chronic inflammation can lead
rapidly to resolution of inflammation (6). Hence, an under-
standing of the process of macrophage emigration from the
inflamed site is essential as it may impact directly upon the
speed of inflammatory resolution and tissue injury.
In peritonitis, monocyte influx occurs directly across the
encompassing peritoneal mesothelial lining and is regulated
by adhesion molecules expressed both on the vascular en-
dothelium and mesothelial cells (7). Efflux is believed to
occur through milky spots found mainly on the subdia-
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phragmatic surface and omentum (2). These provide small
openings in the mesothelial barrier and are intimately asso-
ciated with the draining lymphatics (8).
From these observations, we hypothesized that in the
resolution of peritonitis, specific adhesion molecules regu-
late macrophage adhesion to the mesothelium overlying
the draining peritoneal lymphatics before their emigration.
In addition, this adherence and transmigration provides a
regulatory mechanism governing the rate of macrophage
clearance. We examined the extent to which murine mac-
rophage clearance is regulated in vivo then, using a novel
ex vivo system, Arg-Gly-Asp (RGD) peptides (9) and
blocking antibodies, determined the adhesion molecules
involved. The role of these molecules in regulating mac-
rophage clearance was finally tested in our in vivo peritoni-
tis model.
 
Materials and Methods
 
Reagents and Antibodies.
 
All reagents, unless stated otherwise,
were obtained from Sigma-Aldrich, plasticware and antibodies
were from BD Biosciences, and culture media were from Life
Technologies. The following antibodies were used: CD11a
(M17/4), CD11b (M1/70, 5C6), CD18 (GAME-46, 2E6;
American Type Culture Collection), CD49d (PS/2, R1-2,
9C10), CD49e (5H10-27), CD51 (H9.2B8), and F4/80 (Sero-
tec). FITC-conjugated CD11c (HL3) and biotinylated Ia
 
d 
 
(MHC
class II) were provided by D. Katz, University College London,
London, United Kingdom. Isotype controls were: IgG1 (LO-
DNP-1; Serotec), IgG2a (LO-DNP-16; Serotec), IgG2b (LO-
DNP-11; Serotec), hamster IgM and IgG, and R-phycoerythrin–
conjugated F(ab’)
 
2 
 
goat anti–rat second layer (Star 73; Serotec).
Antibodies for adhesion and in vivo studies were azide free and
low endotoxin.
 
In Vivo Studies of Regulation of Macrophage Clearance.
 
BALB/c
(H-2
 
d
 
) and C3HF/KAM (H-2
 
k
 
) mice (22–28 g) were used for
joint resident/inflammatory macrophage studies. All other exper-
iments used ICR mice (Harlan).
 
Comparison of Resident and Inflammatory Macrophage Clearance.
 
Intraperitoneal injection of 1 ml 4% thioglycollate (TG; Difco)
induced a sterile peritonitis with leukocyte numbers (
 
 
 
93% mac-
rophages) peaking on day 5 and declining to baseline by day 10.
H-2
 
d 
 
peritoneal phagocytes were labeled in vivo by 1 ml 0.5 
 
 
 
M
red fluorescent marker PKH26-PCL intraperitoneally 5 d after
TG
 
2
 
. This labeled 
 
 
 
87% of phagocytes and was cleared rapidly so
no label was acquired by fresh H-2
 
k 
 
macrophages instilled 2 h
later and was distinguished by flow cytometry using FITC-conju-
gated anti–H-2D
 
d 
 
IgM and FITC-conjugated anti–H-2K
 
k 
 
IgG2a
with FITC-conjugated anti-CD15 IgM and FITC-conjugated
anti-CD45RO IgG2a as controls (Dako). Resident phagocytes
were labeled in vivo by 1 ml 0.5 
 
 
 
M green fluorescent dye
PKH2-PCL intraperitoneally in the absence of TG.
Fluorescent resident and inflammatory macrophages were lav-
aged, mixed in a 1:1 ratio of red/green cells (confirmed by flow
cytometry) and 2.5 
 
  
 
10
 
6 
 
or 1.25 
 
  
 
10
 
7 
 
cells instilled intraperito-
neally into mice with no inflammation or 5 d after TG. 3 or 10 d
later abdominal wall, spleen, liver, kidney, para-aortic and para-
thymic lymph nodes, and heart and lung were harvested for fro-
zen sectioning. Macrophage totals in peritoneal lavage were de-
termined from cell counts and differential counts from cytospins,
counting 
 
 
 
400 cells per slide. Resident and inflammatory mac-
rophage numbers were determined by dual color flow cytometry
from percent of green and red cells in gates generated on CD11b
and F4/80
 
  
 
cells. Flow cytometry demonstrated 
 
 
 
2.5% of the
PKH26-PCL–labeled population was CD11c
 
  
 
whereas biotin-
ylated staining showed 
 
 
 
8% positive for MHC class II antigen.
Therefore, few of the fluorescent cells migrating to the lymph
nodes late in inflammation were of dendritic phenotype.
 
In Vivo Modulation of Inflammatory Macrophage Clearance.
 
1 ml
of test agents (GRGDTP peptide [RGD], control RGES peptide
[RGE], PBS, or antibodies) were injected intraperitoneally 2 and
26 h after fluorescently labeling day 5 macrophages. 24 h later
cells were lavaged, macrophages counted, and adhesion molecule
surface expression determined by indirect immunofluorescence.
Mesothelial lining imprints of cecum, spleen, and liver were pre-
pared by applying air-dried tissue onto 5% gelatin-coated slides
and labeled macrophages on these imprints were quantified
blindly by two observers. Parathymic lymph nodes were snap fro-
zen and paired and serial 7-
 
 
 
m frozen sections were cut at 280
 
 
 
m intervals spanning the whole node. Sections were scored
blindly from 0 (no labeled cells) to 8 (maximum labeled cells) by
two observers using predefined control slides. In all cases interob-
server variability was 
 
 
 
15% and the distribution of cells within
nodes was unaffected by treatments.
To outline lymphatics, TG challenged mice were injected in-
traperitoneally with 1 ml India ink or PBS. 30 min later PKH26-
PCL–labeled macrophages were instilled and 1 h later the dia-
phragm was dissected, washed, and the distribution of India ink
and macrophages was determined.
 
Ex Vivo Macrophage–Mesothelial Adhesion.
 
Macrophages from
mice 5 d after TG, were labeled in vitro using 5-chlorometh-
ylfluorescein diacetate (Cambridge Bioscience). Diaphragms from
the same mice were washed, clamped in customized rings (5 mm
internal diameter retaining 100 
 
 
 
l above and 75 
 
 
 
l below the
surface), and orientated with peritoneal mesothelial surface up-
permost. Rings were incubated with test medium for 30 min at
37
 
 
 
C while 1.5–3 
 
  
 
10
 
4 
 
labeled cells were preblocked by rotating
with test medium for 30 min at 4
 
 
 
C before being added to the
upper chamber in Dulbecco’s phosphate-buffered saline. After 1 h,
the rings were washed gently to remove nonadherent cells and
adherent cells were counted. Mesothelial integrity was confirmed
by en face silver staining of intercellular junctions as previously
described (10). To identify lymphatics in ex vivo diaphragmatic
tissue, 100 
 
 
 
l media containing 2 
 
 
 
l India ink was added to the
upper chamber, incubated for 30 min, and washed before the ad-
dition of labeled cells.
 
Determination of Apoptosis.
 
To determine RGD-induced apop-
tosis, cells lavaged 5 d after TG were incubated in Iscove’s modi-
fied DMEM supplemented with 10% FCS, 
 
l
 
-glutamine, 100 U
penicillin, and streptomycin in 8-well slides at 1.5 
 
  
 
10
 
5 
 
cells/
well and up to 0.5 mg/ml RGD or RGE. Cells were examined
for up to 48 h and apoptosis was quantified by nuclear morphol-
ogy and staining with acridine orange (10 
 
 
 
g/ml).
 
Statistics.
 
Data are expressed as mean 
 
  
 
SEM with compari-
son by two-tailed Mann-Whitney U test. Differences were con-
sidered significant if P 
 
  
 
0.05.
 
Results
 
Macrophage Emigration Is Regulated and Depends on Activa-
tion State.
 
Clearance rates of noninflamed (resident) and
inflammatory macrophages in the presence or absence of
inflammation were compared by instilling equal numbers 
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into the peritoneum in the presence/absence of resolving
peritonitis and determining the number remaining after 3
(Fig. 1 A) and 10 d. Recovery of resident macrophages al-
ways exceeded that of inflammatory macrophages with
over three and a half times more resident than inflamma-
tory macrophages recovered from the noninflamed perito-
neum (2.65 
 
  
 
0.25 
 
  
 
10
 
6
 
 vs. 0.72 
 
  
 
0.14 
 
  
 
10
 
6
 
, P 
 
 
 
0.005) and nearly three times more from the inflamed peri-
toneum (1.14 
 
  
 
0.3 
 
  
 
10
 
6 
 
vs. 0.4 
 
  
 
0.07 
 
  
 
10
 
6
 
, P 
 
 
 
0.05). Resolving peritonitis dramatically augmented the
clearance of all macrophages with significantly more resi-
dent (P 
 
  
 
0.005) and inflammatory (P 
 
  
 
0.05) macro-
phages recovered from the noninflamed than the inflamed
peritoneum after 3 d. Differences between resident and in-
flammatory macrophage recovery persisted when examined
after 10 d (0.58 
 
  
 
0.2 
 
  
 
10
 
6 
 
vs. 0.03 
 
  
 
0.03 
 
  
 
10
 
6
 
, P 
 
 
 
0.005 from noninflamed and 0.26 
 
  
 
0.07 
 
  
 
10
 
6 
 
vs. 0.013 
 
 
 
0.007 
 
  
 
10
 
6
 
, P 
 
  
 
0.01 from inflamed peritoneum; 
 
n 
 
 
 
6/group). These differences were maintained when five-
fold fewer cells were transferred (
 
n 
 
  
 
3/group, unpub-
lished data).
Fig. 1 B demonstrates that reduced peritoneal recovery
of inflammatory macrophages was due to faster emigration
into the draining lymphatics as there were always signifi-
cantly more inflammatory than resident macrophages in the
parathymic nodes
 
.
 
 Analysis of the peritoneal lining of the
 
abdominal wall, spleen, liver, kidney, and para-aortic
lymph nodes for fluorescent cells verified that differences
were not due to widespread nonspecific intra-abdominal
adhesion. Consistent with reduced clearance rates in vivo,
resident macrophage adhesion to noninflamed mesothe-
lium was only 71 
 
  
 
4.1% (
 
n 
 
  
 
4, P 
 
  
 
0.05) that of inflam-
matory macrophage adhesion to the inflamed mesothelium
when examined ex vivo.
 
Macrophage–Mesothelial Adhesion Localizes to Areas Overly-
ing Draining Lymphatics.
 
Macrophage–mesothelial adher-
ence was patchy and markedly reduced over the mesothe-
lium lining the tendinous compared with the muscular
portion of the diaphragm, both when adhesion was exam-
ined in vivo or ex vivo. Adherence was localized to the In-
dia ink–positive areas suggesting focal adhesion to particu-
lar mesothelial cells or structures associated with the
draining lymphatics. Macrophage binding to India ink–free
areas was minimal (
 
n 
 
  
 
3, Fig. 2 A). India ink outlined
lymphatic vessels under the diaphragmatic mesothelial sur-
face that contained emigrating macrophages by 1 h (Fig. 2
B). India ink stained multiple small patchy areas to which
macrophages commonly adhered as well as classic milky
spot structures to which macrophages always adhered
strongly (Fig. 2, C and D). Macrophage adhesion was simi-
larly patchy in the absence of India ink, which suggested
this was not an artifact induced by the India ink particles.
 
Very Late Antigen (VLA)-4 and VLA-5 Integrins Regulate
Macrophage–Mesothelial Adhesion Ex Vivo.
 
Fig. 3 A(i) dem-
onstrates that inflammatory macrophage adhesion was
reduced by 70.6 
 
  
 
6% in the absence of divalent cations
(P 
 
  
 
0.0004), 50.5 
 
  
 
5.4% by RGD (P 
 
  
 
0.05), 29.2 
 
 
 
8% by blocking the 
 
 4 chain of VLA-4 (PS/2; P   0.05),
and confirmed by another combination of anti- 4 antibod-
Figure 1. Macrophage emigration is regulated. A total of 12.5   106
fluorescent green–labeled resident and red-labeled inflammatory mac-
rophages were instilled into the peritoneal cavity of mice in the absence
of peritonitis (noninflamed peritoneum) or mice with resolving peritonitis
(inflamed peritoneum). (A) The number of resident (black bars) and in-
flammatory (gray bars) macrophages recovered from the peritoneal cavity
after 3 d is shown. † significantly greater resident than inflammatory mac-
rophage recovery (P   0.05, n   8/group). *, significantly greater recov-
ery from noninflamed than inflamed peritoneum (P   0.05). (B) Fluores-
cent-labeled macrophages in draining parathymic lymph nodes from the
same mice. *, significantly more inflammatory than resident macrophages
(P   0.05, n   8/group).
Figure 2. Macrophage–mesothelial adhesion is localized to regions
overlying the draining lymphatics. (A) Ex vivo preparation of mesothelial
surface of diaphragm with lymphatics localized by India ink. Adherence
of inflammatory macrophages localizes to areas of mesothelium stained
with India ink whereas virtually no macrophages adhere to India ink–free
areas. Similar colocalization is seen when adhesion occurs in vivo. (B)
Macrophages emigrating into draining lymphatics within 1 h of instilla-
tion. (C) India ink labeling of a milky spot and (D) the same section un-
der fluorescent microscopy where fluorescent macrophages are seen to
adhere ( 80).1518 Adhesion Molecules Regulate Macrophage Emigration
ies (R1-2 with 9C10, 20  g/ml each), which decreased
adhesion by 27.2   6%. Blocking VLA-5 (5H10-27) sig-
nificantly inhibited binding by 31.2   11.8% (P   0.05).
In contrast, blocking  v, another RGD-inhibitable inte-
grin, had no effect. The combination of blocking VLA-4
(PS/2) and VLA-5 (5H10-27) significantly increased inhi-
bition of adhesion (46.8    5.7%) over either PS/2 or
5H10-27 alone (P   0.01). In addition, the combination
of RGD with VLA-4 blocking (PS/2) appeared to increase
inhibition over RGD alone, although this was not signifi-
cant at the P   0.05 level (56.9   9 vs. 51.2   6.2). Ad-
hesion in the presence of RGD plus VLA-5 blocking
(5H10-27) was not different to RGD alone (51.1   6.8
vs. 49.8   6).
Importantly, Fig. 3 A(ii) shows that blocking  2 integrin
function with CD11a (M17/4), CD11b (5C6, M1/70),
and CD18 (2E6, GAME-46) blocking antibodies had no
effect on adhesion. However, the combination of VLA-4
(PS/2) with either CD11a or CD11b blocking antibodies
resulted in significantly greater inhibition than with PS/2
alone (57.7   8.2 and 58.5   7.9 vs. 30.9   7.5, respec-
tively; P   0.05). Adhesion was compared with equivalent
concentrations of isotype control antibody, protein alone,
and with F4/80 (used to determine whether there were
any Fc-mediated effects). There was no difference between
these controls. Silver nitrate staining confirmed mesothelial
surface integrity (Fig. 3 B) and adhesion was easily quantifi-
able by fluorescent microscopy (Fig. 3, C and D). Macro-
phage adhesion to the mesothelium lining the abdominal
wall was reduced by  50% compared with the subdia-
phragmatic mesothelium, confirming the specificity of this
region for emigration (P   0.05, n   3). The difference in
adhesion induced by RGD peptide was not due to any
proapoptotic effect of RGD on macrophages altering their
ability to adhere, as there was no difference in the number
of apoptotic cells when peritoneal lavage cells ( 90% mac-
rophages) were exposed to 0.5mg/ml RGD or controls for
up to 48 h in vitro.
Macrophage Emigration In Vivo Is Regulated by VLA-4 and
VLA-5 Integrins. Inflammatory macrophages express sig-
nificant levels of CD11b, CD49d, and CD49e (5.1   0.85,
2.23   0.31, and 2.27   0.48-fold greater than isotype
Figure 3.  1 integrins mediate macrophage–meso-
thelial adhesion. (A) (i) Macrophage–mesothelial ad-
hesion ex vivo is significantly reduced (P   0.05) by
the following: Ca2 /Mg2 -free media (control: Ca2 /
Mg2 -containing media, n   5), 0.5 mg/ml RGD in
standard media (control: RGE, n   5), blocking: VLA-4
(PS/2 10  g/ml, n   6), VLA-5 (5H10–27 10  g/ml,
n   9), VLA-4   VLA-5 (n   7), VLA-4   RGD
(n   9), and VLA-5   RGD (n   8), but not by block-
ing  v (H9.2B8, 10  g/ml, n   6). Controls (isotype
monoclonals, F4/80 and/or RGE) represent 100% ad-
hesion. Adhesion significantly reduced compared to
the following: controls (*), blocking VLA-4 (†), and
blocking VLA-5 (#). (ii) Blocking  2 integrins: CD11a
(M17/4, n   8), CD11b (M1/70, 5C6 both n   6), and CD18 (GAME-46,
2E6 both n   9) do not inhibit adhesion, however blocking both  1 and
 2 integrins, VLA-4   CD11a (n   6) and VLA-4   CD11b (M1/70,
n   6), inhibits adhesion significantly more than blocking  1 integrins alone
(PS/2, n   6). Adhesion was significantly reduced (P   0.05) compared
to the following: controls (*) and blocking VLA-4 (†). (B) En face silver
staining demonstrating the integrity of mesothelial surface after 6 h is
shown ( 300). (C and D) Adhesion of fluorescent-labeled macrophages
to mesothelium ex vivo in the presence of RGD or RGE, which shows
the ease of visual quantification of assay ( 100).1519 Bellingan et al. Brief Definitive Report
controls, respectively; all P   0.05, n   8 mice). Repeated
intraperitoneal injection of RGD significantly delayed
macrophage clearance in vivo as evidenced by increased
numbers of fluorescent macrophages remaining in the peri-
toneum compared with RGE and medium controls (P  
0.05, Fig. 4). In addition, RGD significantly reduced the
number of labeled macrophages in the parathymic nodes in
the RGD-treated mice compared with either control (P  
0.01). Controls were similar for both peritoneal recovery
and lymph node scores. There were no differences be-
tween the groups in the number of fluorescent macro-
phages adherent to bowel, spleen, or liver and the
mesothelial surfaces of these organs remained intact.
Corroborating the ex vivo data, macrophage emigration
into the draining lymphatics was also significantly inhibited
by blocking VLA-4 (PS/2) and VLA-5 (5H10-27), which
increased the number of macrophages remaining in the
peritoneum (P   0.01 for blocking both VLA-4 and VLA-
5) and reduced emigration into the lymphatics (P   0.01
for blocking both VLA-4 and VLA-5). They did not alter
the distribution of macrophages on the mesothelial surface
of spleen, bowel, or liver. Blocking CD11b had no effect
on macrophage clearance in vivo, there being no signifi-
cant difference in macrophage recovery from the perito-
neum for M1/70, isotype, or F4/80 controls (0.89   0.2
vs. 1.18   0.19 and 0.96   0.09   106, respectively; n  
12). Likewise, lymphatic emigration was equally unaffected
by blocking CD11b. Antibody was used at 100  g for each
injection and increasing to 225  g had no additional effect
(n   5, unpublished data).
Discussion
This study demonstrates for the first time that macro-
phage clearance from the inflamed peritoneum can be reg-
ulated, a finding that may have significant implications for
our understanding of mechanisms leading to mononuclear
persistence in chronic inflammation. Macrophages are ca-
pable of undergoing apoptosis, however they are generally
resistant to this and during acute resolving peritoneal in-
flammation are cleared by emigration, not apoptosis (2, 11).
Hence, mechanisms regulating emigration may have pow-
erful effects on inflammation.
Here, we demonstrate a dramatic difference in clearance
between activated and nonactivated macrophages. Nearly
seven times more nonactivated macrophages remained in
the noninflamed peritoneum after 3 d compared with acti-
vated macrophages in the inflamed peritoneum. These ob-
servations, along with the demonstration that adhesion lo-
calizes to the mesothelium overlying lymphatics, suggested
specific adhesion molecule regulation that could be func-
tionally up-regulated by inflammation. Adhesion was diva-
lent cation and largely RGD sensitive and partially inhib-
ited by blocking VLA-4 and VLA-5 but not by blocking
CD11a, CD11b, or CD18, which suggests a predominant
role for  1 integrins. Ex vivo results were validated by in
vivo studies in which RGD and blocking VLA-4
and VLA-5 significantly delayed macrophage clearance,
whereas blocking CD11b was ineffective. Alterations in
peritoneal macrophage recovery was always mirrored by al-
terations in recovery from draining lymph nodes. Controls
confirmed that differences in recovery were not due to
nonspecific widespread adhesion. These data thus confirm a
role for VLA-4 and VLA-5 in regulating inflammatory
macrophage clearance from the inflamed peritoneum.
They do not exclude the possibility that resident cells may
depend on distinct molecular mechanisms for clearance.
Mesothelial cells express intercellular adhesion molecule
1 and vascular cell adhesion molecule 1 and associated fi-
bronectin strands can be demonstrated with inflammation,
hence the ligands for VLA-4 and VLA-5 are present (12).
VLA-5 and  v  binding is RGD inhibitable whereas
VLA-4 binding is normally through LDV-inhibitable not
RGD-inhibitable mechanisms (9, 13). The increased inhi-
bition from the combination of VLA-4 and VLA-5 block-
ing suggests that these two integrins are acting indepen-
Figure 4. VLA-4 and VLA-5 regulate macrophage
clearance from resolving peritonitis. (A) (i) After fluo-
rescently labeling macrophages in vivo, 0.4 mg RGD
or controls, RGE (0.4 mg) or PBS, were injected 2 and
26 h later and macrophage recovery from peritoneum
was determined 24 h later. This was significantly
greater for RGD than controls. *, P   0.05. n   13
RGD, 8 RGE, and 10 PBS. Controls were not differ-
ent. (ii) RGD significantly reduced the number of
macrophages reaching draining lymph nodes compared
with RGE or PBS (§, P   0.01). (B) (i) Blocking VLA-4
(PS/2) led to significantly more macrophages remain-
ing in the peritoneum (§, P   0.01; n   10 VLA-4; 9
controls) and (ii) significantly less in the lymph nodes
(§, P   0.01) than isotype control. (C) (i) Blocking
VLA-5 (5H10–27) led to significantly more macro-
phages remaining in the peritoneum (§, P   0.01; n  
10 VLA-5; 10 controls) and (ii) significantly less in the
lymph nodes (§, P   0.01) than isotype control.1520 Adhesion Molecules Regulate Macrophage Emigration
dently. When combined with RGD, VLA-4 further
decreased adhesion but not significantly, and VLA-5 had
no added effect over that of RGD. Whether vascular cell
adhesion molecule 1 or fibronectin are the ligands respon-
sible for VLA-4–mediated binding is currently unknown.
Both VLA-4 and VLA-5 are expressed on monocytes and
implicated in leukocyte influx into inflamed sites, in par-
ticular for migration through connective tissue (14).
Given mesothelial intercellular adhesion molecule 1 ex-
pression, the lack of effect from blocking  2 integrins was
surprising, however monocyte–fibronectin binding has
been shown to be VLA-5 rather than  2 integrin depen-
dent (15). In addition, the combination of  1 and   2
blocking had significantly greater inhibitory effect than
VLA-4 alone, suggesting  2 integrins are functional but
that  1 function is predominant.
VLA-4 inhibitors can attenuate inflammation, prevent-
ing monocyte and lymphocyte influx and thus potentially
preventing the detrimental effects of excessive leukocyte
accumulation (16, 17). However, we demonstrate a cau-
tionary note about using such inhibitors in established in-
flammation as they can also prevent efflux. If the signal for
leukocyte influx is waning, the balance of inflammatory
cells at the inflamed site depends more on clearance. Hence
the stage and nature of the inflammatory response need to
be considered before modulating the function of these ad-
hesion molecules.
Subdiaphragmatic macrophage–mesothelial adhesion, in
close relationship with the lymphatics, has an anatomical
explanation. Lymphatic drainage of the peritoneal cavity
arises from this surface and the omentum where milky
spots are found (8, 18). Electron microscopy demonstrates
that these consist of dome-shaped mesothelial cells sur-
rounding narrow pores overlying lymphatic vessels. This
may have relevance for malignant cells that also adhere
preferentially to milky spots, however the role of adhesion
molecules in lymphatic metastases has received surprisingly
little attention (19).
In summary, we propose that macrophages bind the me-
sothelium overlying draining lymphatics by integrin-medi-
ated mechanisms involving VLA-4 and VLA-5, and regula-
tion of these interactions affects macrophage emigration
into the lymphatic circulation. As other coelomic cavities
are mesothelial lined, these mechanisms might be impor-
tant after pleural and pericardial inflammation. Moreover,
as macrophage emigration to the lymphatics also occurs
with inflammation in other organs such as the kidney and
lung, an understanding of their clearance mechanisms is
likely to have widespread significance (20, 21). Rapid and
effective macrophage clearance may dictate the time course
of inflammation and be a pivotal event determining the de-
velopment of chronic inflammation. This work thus de-
scribes a newly recognized process that offers potential
novel therapeutic approaches to promote the effective res-
olution of inflammation.
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